BENRALIZUMAB

20994 reported adverse events

Drug classes: Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking BENRALIZUMAB:

# Side effect Count
0 ASTHMA 3144
1 DYSPNOEA 2109
2 DEATH 1738
3 DRUG INEFFECTIVE 1580
4 PNEUMONIA 1218
5 COUGH 1111
6 PRODUCT DOSE OMISSION ISSUE 1078
7 HEADACHE 973
8 WHEEZING 791
9 FATIGUE 679
See all common reactions for BENRALIZUMAB

BENRALIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EOSINOPHIL COUNT ABNORMAL 62 0.0830
1 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 169 0.0828
2 BACTERIAL DISEASE CARRIER 39 0.0535
3 BRONCHIAL WALL THICKENING 36 0.0501
4 BRONCHIAL SECRETION RETENTION 46 0.0361
5 EOSINOPHIL COUNT INCREASED 260 0.0312
6 BRONCHIAL OBSTRUCTION 41 0.0292
7 ASTHMA 3144 0.0278
8 ASTHMATIC CRISIS 87 0.0238
9 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 22 0.0237
See all enriched reactions for BENRALIZUMAB